RINVOQ

Swiss trademark · 710088 · Word mark · In force

Register entry

Registration number
710088
Application number
59120/2017
Status
In force
Type
Word mark
Filed
Jul 19, 2017
Registered
Nov 28, 2017
Published
Nov 28, 2017
Protected until
Jul 19, 2027
Priority
01.02.2017 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate und Substanzen zur Behandlung von viralen, metabolischen, endokrinen, muskuloskelettalen, kardiovaskulären, kardiopulmonalen, urogenitalen, onkologischen, hepatologischen, ophthalmischen, respiratorischen, neurologischen, gastrointestinalen, hormonellen, dermatologischen, psychiatrischen und das Immunsystem sowie sexuelle Dysfunktion betreffenden Erkrankungen und Störungen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 24, 2024

    Agent’s address changed

    Representative
    Baker & McKenzie Zurich, Holbeinstrasse 30, 8034 Zürich → Baker McKenzie Switzerland AG, Holbeinstrasse 30, 8034 Zürich

    Published in Swissreg on 24.01.2024

  2. Mar 28, 2022

    Holder’s address changed

    Owner
    AbbVie Biotechnology Ltd., Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda → Abbvie Biotechnology Ltd., 4th Floor, Washington House, 16 Church Street, Hamilton HM 11, Bermuda

    Published in Swissreg on 28.03.2022

  3. Nov 28, 2017

    Registered

    Published in Swissreg on 28.11.2017

Parties

Holder

AbbVie Biotechnology Ltd

Abbvie Biotechnology Ltd.

4th Floor, Washington House, 16 Church Street, Hamilton HM 11, BM

Agent

Baker McKenzie Switzerland AG

Holbeinstrasse 30, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.